Douglas E. Brough

4.6k total citations · 2 hit papers
72 papers, 3.7k citations indexed

About

Douglas E. Brough is a scholar working on Genetics, Molecular Biology and Epidemiology. According to data from OpenAlex, Douglas E. Brough has authored 72 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Genetics, 34 papers in Molecular Biology and 15 papers in Epidemiology. Recurrent topics in Douglas E. Brough's work include Virus-based gene therapy research (37 papers), Viral Infectious Diseases and Gene Expression in Insects (21 papers) and Hearing, Cochlea, Tinnitus, Genetics (15 papers). Douglas E. Brough is often cited by papers focused on Virus-based gene therapy research (37 papers), Viral Infectious Diseases and Gene Expression in Insects (21 papers) and Hearing, Cochlea, Tinnitus, Genetics (15 papers). Douglas E. Brough collaborates with scholars based in United States, Germany and Japan. Douglas E. Brough's co-authors include Imre Kovesdi, Thomas J. Wickham, Peter W. Roelvink, Kohei Kawamoto, Yehoash Raphael, Ryosei Minoda, Hinrich Staecker, Mark Praetorius, David F. Dolan and Donald L. Swiderski and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Douglas E. Brough

72 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals

2005 547 citations Ryosei Minoda, Kohei Kawamoto et al. profile →
The Coxsackievirus-Adenovirus Receptor Protein Can Function as a Cellular Attachment Protein for Adenovirus Serotypes from Subgroups A, C, D, E, and F

1998 524 citations Peter W. Roelvink, Alena Lizonová et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas E. Brough United States	27	1.8k	1.6k	1.2k	708	466	72	3.7k
Luk H. Vandenberghe United States	51	7.1k 3.9×	5.7k 3.6×	687 0.6×	953 1.3×	352 0.8×	126	10.1k
Kazunori Nishizaki Japan	32	1.1k 0.6×	167 0.1×	794 0.7×	454 0.6×	334 0.7×	344	4.5k
Delphine Samson France	11	2.0k 1.1×	1.4k 0.9×	157 0.1×	200 0.3×	57 0.1×	13	4.1k
James Walsh Australia	20	1.6k 0.9×	271 0.2×	1.0k 0.9×	34 0.0×	147 0.3×	59	2.8k
Jacques Loiselet Lebanon	25	1.3k 0.8×	490 0.3×	547 0.5×	52 0.1×	180 0.4×	60	2.6k
Romain Zufferey Switzerland	22	5.7k 3.2×	4.4k 2.7×	97 0.1×	1.2k 1.7×	106 0.2×	30	8.2k
Andrea Amalfitano United States	37	1.7k 0.9×	1.7k 1.0×	91 0.1×	476 0.7×	33 0.1×	67	3.5k
César D. Fermin United States	21	876 0.5×	314 0.2×	317 0.3×	116 0.2×	59 0.1×	60	2.2k
Yoshiaki Kikkawa Japan	28	1.1k 0.6×	683 0.4×	573 0.5×	100 0.1×	127 0.3×	89	2.3k
Xiao-Jun Ma United States	9	1.2k 0.7×	236 0.1×	55 0.0×	446 0.6×	69 0.1×	9	2.5k

Countries citing papers authored by Douglas E. Brough

Since Specialization

Citations

This map shows the geographic impact of Douglas E. Brough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas E. Brough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas E. Brough more than expected).

Fields of papers citing papers by Douglas E. Brough

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas E. Brough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas E. Brough. The network helps show where Douglas E. Brough may publish in the future.

Co-authorship network of co-authors of Douglas E. Brough

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas E. Brough. A scholar is included among the top collaborators of Douglas E. Brough based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas E. Brough. Douglas E. Brough is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Castellví, I., Ma Àngels Ortiz, Douglas E. Brough, et al.. (2023). Impaired Regulation by IL-35 in Systemic Sclerosis. International Journal of Molecular Sciences. 24(13). 10567–10567. 4 indexed citations

Norberg, Scott M., Ke Bai, Cem Sievers, et al.. (2023). The tumor microenvironment state associates with response to HPV therapeutic vaccination in patients with respiratory papillomatosis. Science Translational Medicine. 15(719). eadj0740–eadj0740. 15 indexed citations

Barrera, José, Marvin J. Grubman, David A. Brake, et al.. (2018). Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine. Vaccine. 36(8). 1078–1084. 12 indexed citations

Neilan, John G., José Barrera, Laszlo Zsak, et al.. (2018). Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model. BMC Veterinary Research. 14(1). 254–254. 7 indexed citations

Mori, Keisuke, T. Shoji, Peter Gehlbach, et al.. (2014). Ocular Localization and Transduction by Adenoviral Vectors Are Serotype-Dependent and Can Be Modified by Inclusion of RGD Fiber Modifications. PLoS ONE. 9(9). e108071–e108071. 15 indexed citations

Cranfield, Michael R., Grace P. Lee, A. R. Glenn, et al.. (2013). Adenoviruses isolated from wild gorillas are closely related to human species C viruses. Virology. 444(1-2). 119–123. 19 indexed citations

Durham, Dianne, et al.. (2012). Canalostomy as a Surgical Approach for Cochlear Gene Therapy in the Rat. The Anatomical Record. 295(11). 1830–1836. 17 indexed citations

Kraft, Shannon, et al.. (2011). Atoh1 induces auditory hair cell recovery in mice after ototoxic injury. The Laryngoscope. 123(4). 992–999. 40 indexed citations

McVey, Duncan, Mohammed Zuber, Damodar Ettyreddy, et al.. (2010). Characterization of human adenovirus 35 and derivation of complex vectors. Virology Journal. 7(1). 276–276. 12 indexed citations

10.

Baker, Kim, Douglas E. Brough, & Hinrich Staecker. (2009). Repair of the Vestibular System via Adenovector Delivery of Atoh1: A Potential Treatment for Balance Disorders. Advances in oto-rhino-laryngology. 66. 52–63. 26 indexed citations

11.

Hamilton, Melissa, Gordon A. Byrnes, Jason G. Gall, et al.. (2008). Alternate serotype adenovector provides long-term therapeutic gene expression in the eye.. PubMed. 14. 2535–46. 26 indexed citations

12.

McVey, Duncan, et al.. (2008). Repeat Administration of Proteins to the Eye With a Single Intraocular Injection of an Adenovirus Vector. Molecular Therapy. 16(8). 1444–1449. 5 indexed citations

13.

Praetorius, Mark, Kim Baker, Douglas E. Brough, Peter K. Plinkert, & Hinrich Staecker. (2006). Pharmacodynamics of adenovector distribution within the inner ear tissues of the mouse. Hearing Research. 227(1-2). 53–58. 14 indexed citations

14.

Staecker, Hinrich, Douglas E. Brough, Mark Praetorius, & Kim Baker. (2004). Drug delivery to the inner ear using gene therapy. Otolaryngologic Clinics of North America. 37(5). 1091–1108. 34 indexed citations

15.

Kawamoto, Kohei, et al.. (2003). Math1Gene Transfer Generates New Cochlear Hair Cells in Mature Guinea PigsIn Vivo. Journal of Neuroscience. 23(11). 4395–4400. 343 indexed citations

16.

Wang, Kai, Paul Kessler, Zhongmin Zhou, et al.. (2003). Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented model. Molecular Therapy. 7(5). 597–603. 34 indexed citations

17.

Bruder, Joseph T., Ping Chen, Jie Tian, et al.. (2000). Improved Production of Adenovirus Vectors Expressing Apoptotic Transgenes. Human Gene Therapy. 11(1). 139–149. 19 indexed citations

18.

Wickham, Thomas J., Peter W. Roelvink, Douglas E. Brough, & Imre Kovesdi. (1996). Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nature Biotechnology. 14(11). 1570–1573. 276 indexed citations

19.

Brough, Douglas E., Gustavo Droguett, Marshall S. Horwitz, & Daniel F. Klessig. (1993). Multiple Functions of the Adenovirus DNA-Binding Protein Are Required for Efficient Viral DNA Synthesis. Virology. 196(1). 269–281. 13 indexed citations

20.

Vos, Hans L., Douglas E. Brough, Rob C. Hoeben, et al.. (1989). Characterization of adenovirus type 5 insertion and deletion mutants encoding altered DNA binding proteins. Virology. 172(2). 634–642. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact